RxDoctor Payments DataLook up a doctor →

Sureka Bollepalli

Pediatric Endocrinology · Tampa, FLNPI 1871700948

Payments from drug & device makers

$2,769,757in general payments, 2019–2025

Across 846 payments — averaging $3273.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$971K
  • Novartis$558K
  • Eli Lilly$246K
  • Anika Therapeutics, Inc.$226K
  • Madrigal Pharmaceuticals$222K
  • Genentech, Inc.$178K
  • plus $369K from 10 others
$82,681in research payments, 2019–2025

Across 4 payments — averaging $20,670 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$83K
  • Novo Nordisk$50

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,769,757 in reported general payments places this provider in the 95th percentile of 102 pediatric endocrinology providers in Florida.

See all pediatric endocrinology providers in Florida

Other pediatric endocrinology in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →